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ABSTRACT
Identification of robust biomarkers for cancer prognosis based on gene expres-
sion data is an important research problem in translational genomics. The high-
dimensional and small-sample-size data setting makes the prediction of biomarkers
very challenging. Biomarkers have been identified based solely on gene expression
data in the early stage. However, very few of them are jointly shared among in-
dependent studies. To overcome this irreproducibility, the integrative approach has
been proposed to identify better biomarkers by overlaying gene expression data with
available biological knowledge and investigating genes at the modular level. These
module-based markers jointly analyze the gene expression activities of closely associ-
ated genes; for example, those that belong to a common biological pathway or genes
whose protein products form a subnetwork module in a protein-protein interaction
network. Several studies have shown that modular biomarkers lead to more accurate
and reproducible prognostic predictions than single-gene markers and also provide
the better understanding of the disease mechanisms.
We propose novel methods for identifying modular markers which can be used to
predict breast cancer prognosis. First, to improve identification of pathway markers,
we propose using probabilistic pathway activity inference and relative expression
analysis. Then, we propose a new method to identify subnetwork markers based
on a message-passing clustering algorithm, and we further improve this method by
incorporating topological attribute using association coefficients. Through exten-
sive evaluations using multiple publicly available datasets, we demonstrate that all
of the proposed methods can identify modular markers that are more reliable and
reproducible across independent datasets compared to those identified by existing
ii
methods, hence they have the potential to become more effective prognostic cancer
classifiers.
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1. INTRODUCTION
Advancement in microarray and sequencing technologies has enabled analysis of
gene expressions on a genome-wide scale, leading to the translational and functional
genomics research. This research aims to screen for phenotype-related genes (or
gene combinations) and to utilize genomic signals to classify disease [4]. One of the
important problems in this field is to find reliable diagnosis and prognosis of complex
diseases based on genome-wide expression profiles. This problem regularly involves
a small sample size of clinical data from patients with a vastly large number of genes
that can be seen as the high-dimensional and small-sample-size feature selection
issue. This problem generally involves heterogeneity across patients and samples.
These statements make this problem practically difficult and very challenging.
Over the last decade, several research studies have been working on classify-
ing type or state of human diseases, trying to identify disease-related genes – or
“biomarkers” – from microarray gene expression data. The biomarkers identified
solely from gene expression data have been shown to be good candidates for building
classifiers for disease prediction. However, these gene-based biomarkers have limi-
tations. For instance, two large-scale-dataset studies of breast cancer [5, 6] tried to
find the gene markers that predict metastasis. These studies practically searched
for key genes that show differential expression under distinct phenotype. Both of
them identified approximately 70 gene markers with the accuracy rate of 60-70%.
Surprisingly, they shared only 3 genes from 55 of possible genes that might share
across two different microarray platforms [7]. Moreover, these gene-based markers
yielded low classification performance across different datasets.
Many studies have attempted to improve prediction accuracy and reproducibility
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of the biomarkers. One of the possible ways is based on the assumption that the
progression of complex diseases involves dysregulation of multiple genetic processes.
Therefore, it might be beneficial to interpret multiple genes that are known to be
in the similar biological pathways or genes whose protein products are functionally
related (or belong to the same biological function) as a single attribute [8–14]. In
order to do this, biological information sources compiled by experts, such as gene
sets, pathways, and protein-protein interaction (PPI) network, have been utilized
with gene expression profiles. This leads us to the concept of “integrative approach”
where gene expression is analyzed and interpreted at modular level through data
integration. The biomarker obtained from this approach is called “modular marker”.
This approach has a potential to yield better biomarkers in terms of accuracy and
reproducibility. Moreover, it allows us to view the gene expression in function-
organized fashion, which may facilitate the prediction of system-level features based
on the markers.
The rest of this dissertation is organized as follows: In chapter 2, we propose a
new strategy to identify pathway markers based on relative expression analysis and
probabilistic inference. We evaluate the classification performance of obtained mark-
ers on independent datasets and different normalization methods. In chapter 3 and
4, to overcome the limited amount of available pathway information, we utilize PPI
network to identify subnetwork markers. In chapter 3, we propose a new method for
identifying subnetwork markers by adopting message-passing clustering algorithm.
We demonstrate how to define inputs and employ the algorithm to this type of prob-
lem. We assess the performance of obtain subnetwork markers and compare to the
markers identified by existing methods. In chapter 4, we improve its performance
by using topological information. We study the impact from various association in-
dices that we use to estimate the topological information on different independent
2
datasets. Finally, we draw overall conclusions in chapter 5.
3
2. IDENTIFICATION OF ROBUST PATHWAY MARKERS FOR CANCER
THROUGH RANK-BASED PATHWAY ACTIVITY INFERENCE∗
2.1 Introduction
There has been significant amount of work on identifying markers and build-
ing classifiers that can be used to predict breast cancer metastasis. Many existing
methods have directly employed gene expression data without any knowledge of the
interrelations between genes. As a result, the predicted gene markers often lack in-
terpretability and many of them are not reproducible in other independent datasets.
To overcome these problems, several different approaches have been proposed so
far. For example, a recent work by Geman et al. [15] proposed an approach that
utilizes the relative expression between genes, rather than their absolute expression
values. It was shown that the resulting markers are easier to interpret, robust to
chip-to-chip variations, and more reproducible across datasets.
Another possible way to address the aforementioned problems is the concept of
modular marker through known biological data integration. Modular markers, such
as pathway markers and subnetwork markers, which have been shown to improve
the classification performance and also to be more reproducible across independent
datasets [11–14].
In order to utilize pathway markers, we need to infer the pathway activity by
integrating the gene expression data with pathway knowledge. For example, Guo et
al. [9] used the mean or median expression value of the member genes (that belong
to the same pathway) as the activity level of a given pathway. Recently, Su et
∗Part of this chapter is reprinted from “Navadon Khunlertgit, and Byung-Jun Yoon.
Identification of Robust Pathway Markers for Cancer through Rank-Based Pathway Ac-
tivity Inference. Advances in Bioinformatics, vol. 2013, no. 618461, 2013.
doi:10.1155/2013/618461” [1] c© [2013] Navadon Khunlertgit and Byung-Jun Yoon.
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al. [13] proposed a probabilistic pathway activity inference method that uses the log-
likelihood ratio between different phenotypes based on the expression level of each
member gene.
In this chapter, we propose an enhanced pathway activity inference method that
utilizes the ranking of the member genes to predict the pathway activity in a prob-
abilistic manner. The immediate goal is to identify better pathway markers that
are more reliable, more reproducible, and easier to interpret. Ultimately, we aim
to utilize these markers to build accurate and robust diseases classifiers. The pro-
posed method is motivated by the relative gene expression analysis strategy proposed
in [15,16] and it builds on the concept of probabilistic pathway activity inference pro-
posed in [13,14]. In this chapter, we focus on predicting breast cancer metastasis and
demonstrate that the proposed method outperforms existing methods. Preliminary
results of this work have been originally presented at [17].
2.2 Materials and Methods
2.2.1 Study Datasets
Six independent breast cancer microarray gene expression datasets have been
used in this study: GSE2034 (USA) [6], NKI295 (Netherlands) [18], GSE7390 (Bel-
gium) [19], GSE1456 (Stockholm) [20], GSE15852 [21], and GSE9574 [22]. The
Netherlands dataset uses a custom Agilent chip and it has been obtained from the
Stanford website [23]. All datasets have been profiled using the Affymetrix U133a
platform and they have been downloaded from the Gene Expression Omnibus (GEO)
website [24],
The above datasets have been used in our study both with and without re-
normalization. To test the reproducibility of pathway markers, we selected the USA
dataset and the Belgium dataset, both of which were obtained using the Affymetrix
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platform. The raw data for these two datasets have been normalized by utilizing
the microarray pre-processing methods provided in the Bioconductor package [25].
We applied three popular normalization methods – RMA [26], GCRMA [27], and
MAS5 [28] – with default setting.
The pathway data have been obtained from the Molecular Signatures Database
(MSigDB) 3.0 Canonical Pathways [29]. This pathway dataset consists of 880 path-
ways, where 3,698 genes in these pathways intersect with all datasets.
2.2.2 Gene Ranking
In this study, we utilize “gene ranking” or the relative ordering of the genes based
on their expression levels within each profile [15]. Consider a pathway that contains
n member genes G = {g1, g2, ..., gn} after removing the genes that are not included
in all datasets. Given a sample xk = {x1k, x2k, ..., xnk} that contains the expression
level of the member genes, the gene ranking rk is defined as follows
rk = {ri,jk |1 ≤ i < j ≤ n} (2.1)
where
ri,jk =
 1 if x
i
k < x
j
k
0 otherwise
The resulting gene ranking rk is a binary vector representing the ordering of the
member genes based on their expression values in the k-th sample xk. To preserve the
gene ranking in each sample, we do not employ any between-sample normalization.
2.2.3 Pathway Activity Inference Based on Gene Ranking
To infer the pathway activity, we follow the strategy proposed in [13], where the
activity level ak of a given pathway in the k-th sample is predicted by aggregating
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the probabilistic evidence of all the member genes. The main difference between the
strategy proposed in this study and the original strategy [13] is that we estimate
the probabilistic evidence provided by each gene based on its ranking rather than its
expression value. More specifically, the pathway activity level is given by
ak =
∑
1≤i<j≤n
λi,j
(
ri,jk
)
, (2.2)
where λi,j(r
i,j
k ) is the log-likelihood ratio (LLR) between the two phenotypes (i.e.,
class labels) for the ranking rk. The LLR λi,j(r
i,j
k ) is defined as
λi,j(r
i,j
k ) = log
[
f 1i,j(r
i,j
k )/f
2
i,j(r
i,j
k )
]
, (2.3)
where f 1i,j(r) is the conditional probability mass function (PMF) of the ranking of
the expression level of gene gi and gene gj under phenotype 1 and f
2
i,j(r) is the
conditional PMF of the ranking of the expression level of gene gi and gene gj under
phenotype 2.
In practice, the number of possible gene pairs
(
n
2
)
may be too large when we
have large pathways with many member genes (i.e., when n is large). To reduce
the computational complexity, we prescreen the gene pairs based on the mutual in-
formation [30] as follows. For every gene pair (i, j), we first compute the mutual
information between the ranking ri,jk and the corresponding phenotype ck. Then
we select the top 10% gene pairs with the highest mutual information and use only
these gene pairs for computing the pathway activity level defined in (2.2). Although
we selected the top 10% gene pairs for simplicity, this may not be not be necessar-
ily optimal and one may also think of other strategies for adaptively choosing this
threshold.
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In a practical setting, we may not have enough training data to reliably estimate
the PMFs f 1i,j(r) and f
2
i,j(r). For this reason, we normalize the original LLR λi,j(r
i,j
k )
as follows to decrease its sensitivity to small alterations in gene ranking
λˆi,j(r
i,j
k ) =
λi,j(r
i,j
k )− µ(λi,j)
σ(λi,j)
, (2.4)
where µ(λi,j) and σ(λi,j) are the mean and standard deviation of λi,j(r
i,j
k ) across all
k = 1, · · · , n. Figure 2.1 illustrates the overall process.
2.2.4 Assessing the Discriminative Power of Pathway Markers
In order to assess the discriminative power of a pathway marker, we compute the
t-test statistics score, which is given by
t(a) =
µ1 − µ2√
σ1/K1 + σ2/K2
, (2.5)
where a = {ak} is the set of inferred pathway activity levels for a given pathway, µ`
and σ` represent the mean and the standard deviation of the pathway activity levels
for samples with phenotype ` ∈ {1, 2}, respectively, and K` represents the number
of samples in the dataset with phenotype `. This measure has been widely used in
previous studies to evaluate the performance of pathway markers [12, 13].
2.2.5 Evaluation of the Classification Performance
In order to evaluate the classification performance, we use the Area Under ROC
Curve (AUC). Many previous studies [11–14] have utilized AUC due to its ability to
summarize the efficacy of a classification method over the entire range of specificity
and sensitivity. We compute the AUC based on the method proposed in [31]. Given
a classifier, let x1, x2, ..., xm be the output of the classifier for m positive samples,
8
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Figure 2.1: Probabilistic inference of rank-based pathway activity [1]. For a given
pathway, we first compute the ranking of the members genes for each individual
sample in the dataset. Then we estimate the conditional probability mass function
(PMF) of the gene ranking under each phenotype. Next, we transform the gene
ranking into LLRs based on the estimated PMFs and normalize the LLR matrix.
Finally, the pathway activity level is inferred by aggregating the normalized LLRs of
the member genes.
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and y1, y2, ..., yn be the output for n negative samples. The AUC of the classifier can
be computed as follows
A =
1
mn
m∑
i=1
n∑
j=1
I (xi > yj) , (2.6)
where
I(xi > yj) =
 1 if xi > yj0 otherwise
2.3 Results and Discussion
2.3.1 Discriminative Power of the Pathway Markers Using the Proposed Method
In order to assess the performance of the rank-based pathway activity inference
method proposed in this study, we first evaluated the discriminative power of the
pathway markers following a similar set-up that was adopted in a number of previous
studies [12,13]. For comparison, we also evaluated the performance of the mean and
median-based schemes proposed in [9], and the original probabilistic pathway activity
inference method (we refer to this method as the “LLR method” for simplicity)
presented in [13]. As explained in Methods, the discriminative power of a pathway
marker was measured based on the absolute t-test score of the inferred pathway
activity level. Then the pathway markers were sorted according to their t-score, in
a descending order.
Figure 2.2 shows the discriminative power of the pathway markers on the six
datasets using different activity inference methods. On each dataset, we computed
the mean absolute t-test statistics score of the top P% pathways for each of the four
pathway activity inference methods. The x-axis corresponds to the proportion (P%)
of the top pathway markers that were considered and the y-axis shows the mean
absolute t-test score for these pathway markers. As we can see from Figure 2.2, the
10
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Figure 2.2: Discriminative power of pathway markers. Each dataset is used as pub-
lished by their original studies [1]. We computed the mean absolute t-score of the
top P% markers for each dataset without any further normalization.
proposed method clearly improves the discriminative power of the pathway markers
on all six datasets that we considered in this study. In order to investigate the
effect of normalization on the discriminative power of the pathway activity inference
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Figure 2.3: Discriminative power of pathway markers across different datasets. Each
dataset is used as published by their original studies [1]. The pathway markers have
been ranked and sorted using the first dataset and their discriminative power has
been re-evaluated using the second dataset. As before, the mean absolute t-score
was used for assessing the discriminative power.
methods, we repeated this experiment using the USA and the Belgium datasets,
where we first normalized the raw data using three different normalization methods
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(RMA, GCRMA, and MAS5) then evaluated the discriminative power of the pathway
markers. The results are summarized in Figure 2.4, where we can see that the
proposed rank-based scheme is not very sensitive to the choice of the normalization
method and performs consistently well in all cases.
Next, we investigated how the top pathway markers identified on a specific dataset
perform in other independent datasets. We first ranked the pathway markers based
on their mean absolute t-test statistics score in one of the datasets, and then esti-
mated the discriminative power of the top P% markers on a different dataset. These
results are shown in Figure 2.3, where the first dataset is used for ranking the mark-
ers and the second dataset is used for assessing the discriminative power. As we can
see from Figure 2.3, the pathway markers identified using the mean and the median-
based schemes do not retain their discriminative power very well in other datasets.
Both the LLR-method [13] and the proposed rank-based inference method perform
well across different datasets, where the proposed method clearly outperforms the
previous LLR-method. It is interesting to see that the discriminative power of the
markers is retained even when we consider datasets that are obtained using different
platforms. For example, USA/Belgium datasets are profiled on the U133a platform
and the Netherlands dataset is profiled on a custom Agilent chip, but Figure 2.3
shows that pathway markers identified using the proposed method retain their dis-
criminative power across these datasets. As before, we repeated these experiments
after normalizing the datasets using different normalization methods. The results
are depicted in Figure 2.5, where we can see that the proposed method works very
well, regardless of the normalization method that was used. Interestingly, this is
also true even when the first dataset and the second dataset are normalized using
different methods, as shown in Figures 2.6 and 2.7.
Another interesting observation is that the rank-based method can overcome
13
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Figure 2.4: Discriminative power of pathway markers identified on re-normalized
datasets [1]. We computed the mean absolute t-score of the top P% markers for the
USA and the Belgium datasets after normalizing the raw data using three different
normalization methods: RMA, GCRMA, and MAS5.
one of the limitations of the previous LLR-method. For example, normalization of
the Belgium dataset using GCRMA results makes the LLR-method fail, as some of
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the genes loose variability and some of the LLR values become infinite. We can
see this issue in Figures 2.4 d, 2.5 c, 2.6 a, and 2.6 f. However, this limitation is
easily overcome by the proposed method through the use of gene ranking and the
preselection of informative gene pairs based on mutual information.
2.3.2 Classification Performance of the Pathway Markers Using the Proposed
Method
Next, we evaluated the classification performance of the proposed rank-based
pathway activity inference method. For this purpose, we performed five-fold cross-
validation experiments, following a similar set-up used in previous studies [11–14].
We first performed the within-dataset experiments for each of the six datasets. First,
a given dataset was randomly divided into five folds, where four folds (“training
dataset”) were used for constructing a Linear Discriminant Analysis (LDA) classifier
and the remaining fold (“testing dataset”) was used for evaluating its performance.
To construct the classifier, the training dataset was again divided into three folds,
where two folds (“marker-evaluation dataset”) were used for evaluating the pathway
markers and the remaining one fold (“feature-selection dataset”) for feature selection.
The entire training dataset was used for PDF/PMF estimation. The overall set-up
is shown in Figure 2.8a.
In order to build the classifier, we first evaluated the discriminative power of each
pathway on the marker-evaluation dataset. The pathways were sorted according to
their absolute t-test statistics score in a descending order and the top 50 pathways
were selected as potential features. Initially, we started with a LDA-based classi-
fier with a single feature (i.e., the pathway marker that is on the top of the list),
and continued to expand the feature set by considering additional pathway markers
in the list. The classifier was trained using the marker-evaluation dataset and its
15
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Figure 2.5: Discriminative power of pathway markers across re-normalized datasets
[1]. The pathway markers have been ranked and sorted using the first dataset and
their discriminative power has been re-evaluated using the second dataset. In all
experiments, the datasets have been first normalized using the same normalization
method.
performance was assessed on the feature-selection dataset by measuring the AUC.
Pathway markers were added to the feature set only when they increased the AUC.
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Figure 2.6: Discriminative power of pathway markers identified on re-normalized
USA dataset and evaluated on re-normalized Belgium dataset [1]. The pathway
markers have been ranked and sorted using the USA dataset and their discriminative
power has been re-evaluated using the Belgium dataset. In these experiments, the
two datasets have been normalized using different normalization methods.
Finally, the performance of the classifier with the optimal feature set was evaluated
by computing the AUC on the testing dataset. The above process was repeated for
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Figure 2.7: Discriminative power of pathway markers identified on re-normalized
Belgium dataset and evaluated on re-normalized USA dataset [1]. The pathway
markers have been ranked and sorted using the Belgium dataset and their discrim-
inative power has been re-evaluated using the USA dataset. In these experiments,
the two datasets have been normalized using different normalization methods.
100 random partitions to ensure reliable results, and we report the average AUC as
the measure of overall classification performance.
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Figure 2.8: Experimental setup for evaluating the classification performance [1]. (a)
The set-up for the within-dataset experiment. (b) The set-up for the cross-dataset
experiment.
Figure 2.9 shows how the respective classifiers that use different pathway activity
inference methods perform on different datasets. As we can see in Figure 2.9, among
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Figure 2.9: Classification performance for within-dataset experiments [1]. The bars
show the classification performance (average AUC) of different pathway activity in-
ference methods evaluated on various breast cancer datasets.
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Figure 2.10: Classification performance for within-dataset experiments based on re-
normalized datasets [1]. We repeated the within-dataset classification experiments
based on the USA and the Belgium datasets after normalizing the raw data using
three different normalization methods: RMA, GCRMA, and MAS5.
the four inference methods, the proposed rank-based scheme typically yields the best
average performance across these datasets. We also performed similar experiments
based on the USA and the Belgium dataset after normalizing the raw data using
different normalization methods. These results are summarized in Figure 2.10. We
can see from Figure 2.10 that the proposed method yields the best performance on
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the USA dataset for all three normalization methods. On the Belgium dataset, the
proposed method yields good consistent performance that is not very sensitive to the
normalization method.
2.3.3 Reproducibility of the Pathway Markers Identified by Proposed Method
To assess the reproducibility of the pathway markers, we performed the following
cross-dataset experiments based on a similar set-up that has been utilized in previous
studies [11–14]. In this experiment, we used one of the breast cancer datasets for
selecting the best pathway markers (i.e., only for feature selection) and a different
dataset for building the classifier (using the selected pathways) and evaluating the
performance of the resulting classifier. More specifically, we proceeded as follows.
The first dataset was first divided into three folds, where two folds were used for
marker evaluation and the remaining fold was used for feature selection. The second
dataset was randomly divided into five folds, where four folds were used to train the
LDA classifier, using the features selected from the first dataset, and the remaining
fold was used to evaluate the classification performance. The overall set-up is shown
in Figure 2.8b. To obtain reliable results, we repeated this experiment for 100 random
partitions (of the second dataset) and report the average AUC as the performance
metric. For these experiments, we used the three largest breast cancer datasets
(USA, Netherlands, and Belgium) among the six.
The results of the cross-dataset classification experiments are shown in Fig-
ure 2.11. As we can see from this figure, the proposed rank-based inference scheme
typically outperforms other methods in terms of reproducibility. Furthermore, we
can also observe that proposed method yields consistent classification performance
across experiments, while the performance of other inference methods are much more
sensitive on the choice of the dataset. Next, we repeated the cross-dataset classifi-
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Figure 2.11: Classification performance for cross-dataset experiments [1]. The bars
show the cross-dataset classification performance (average AUC) of different pathway
activity inference methods. The first dataset was used for selecting the pathway
markers and the second dataset was used for training and evaluation of the classifier.
The three largest breast cancer datasets were used: USA (U), Netherlands (N),
Belgium (B).
cation experiments based on the USA and the Belgium datasets after normalizing
the raw data using RMA, GCRMA, and MAS5. As shown in Figure 2.12, the pro-
posed method yields consistently good performance, regardless of the normalization
method that was used.
Finally, we performed additional cross-dataset experiments after normalizing the
USA and the Belgium datasets using different normalization methods. These results
are summarized in Figures 2.13 and 2.14. We can see that the proposed pathway
activity inference scheme is relatively robust to “normalization mismatch.” More-
over, these results also show that the proposed scheme overcomes the problem of the
previous LLR-based scheme [13] when used with GCRMA (see Figures 2.12, 2.13
and 2.14)
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Figure 2.12: Classification performance for cross-dataset experiments based on re-
normalized datasets [1]. We repeated the cross-dataset experiments based on the
USA and the Belgium datasets after normalizing the raw data using same normal-
ization method.
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Figure 2.13: Classification performance for re-normalized USA-Belgium cross-dataset
experiments [1]. The USA dataset was used to select the pathway markers and the
Belgium dataset was for training and evaluating the classifier. In these experiments
the two datasets have been normalized using different normalization methods.
2.4 Conclusions
In this chapter, we proposed an improved pathway activity inference scheme,
which can be used for finding more robust and reproducible pathway markers for
predicting breast cancer metastasis. The proposed method integrates two effective
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Figure 2.14: Classification performance for re-normalized Belgium-USA cross-dataset
experiments [1]. The Belgium dataset was used to select the pathway markers and
the USA dataset was for training and evaluating the classifier. In these experiments
the two datasets have been normalized using different normalization methods.
strategies that have been recently proposed in the field: namely, the probabilistic
pathway activity inference method [13] and the ranking-based relative gene expres-
sion analysis approach [15]. Experimental results based on several breast cancer gene
expression datasets show that our proposed inference method identifies better path-
way markers that have higher discriminative power, are more reproducible, and can
lead to better classifiers that yield more consistent performance across independent
datasets.
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3. SIMULTANEOUS IDENTIFICATION OF ROBUST SYNERGISTIC
SUBNETWORK MARKERS FOR EFFECTIVE CANCER PROGNOSIS∗
3.1 Introduction
So far, it has been shown that pathway markers tend to be more effective and
robust compared to traditional gene markers [1, 8, 9, 12, 13]. Unfortunately, the use-
fulness of pathway markers is practically limited by our incomplete pathway knowl-
edge. In fact, currently known pathways cover only a relatively small number of
genes, hence the reliance on pathway markers may result in excluding crucial genes
that may play important roles in determining the phenotypes of interest.
The concept of subnetwork markers has been originally proposed to address the
weakness of pathway markers [10, 11]. The main idea is to overlay the PPI network
with the gene expression data to identify potential “subnetwork markers,” which
consist of discriminative genes whose protein products interact with each other, hence
connected in the PPI network. Conceptually, we can find such subnetwork markers
by identifying subnetwork regions that undergo significant differential expression
across different phenotypes, and the detected subnetwork markers may potentially
correspond to functional modules – such as signaling pathways or protein complexes
– in the underlying biological network. PPI networks provide a much better gene
coverage compared to the set of currently known pathways, hence this network-
based approach can essentially overcome the major shortcoming of the pathway-based
approach.
Until now, several different strategies have been proposed for identifying sub-
∗Part of this chapter is reprinted from “Navadon Khunlertgit, and Byung-Jun Yoon. Simul-
taneous Identification of Robust Synergistic Subnetwork Markers for Effective Cancer Progno-
sis. EURASIP Journal on Bioinformatics and Systems Biology, vol. 2014, no. 1, p. 19, 2014.
doi:10.1186/s13637-014-0019-9” [2] c© [2014] Navadon Khunlertgit and Byung-Jun Yoon.
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network markers. For example, Chuang et al. [11] proposed an efficient algorithm
for finding subnetwork markers, where they first identify highly discriminative seed
genes and then greedily grow the subnetworks around the seed genes to maximize the
mutual information between the average z-score of the member genes and the class
label. More recently, Su et al. [14] proposed a different strategy, where differentially
expressed linear paths are found by dynamic programming and overlapping paths are
combined to obtain discriminative subnetwork markers. Both studies [11, 14] have
shown that subnetwork markers can lead to more accurate and robust classifiers,
compared to pathway markers.
In this chapter, we propose a novel method for identifying effective subnetwork
markers for predicting cancer prognosis. The proposed method is based on an ef-
ficient message-passing algorithm, called affinity propagation, which can be used
to efficiently identify clusters of discriminative and synergistic genes whose protein
products are either connected or closely located in the PPI network. Unlike previous
subnetwork marker identification methods, the proposed method can simultaneous
predict multiple subnetwork markers, which are mutually exclusive and have the po-
tential to accurate predict cancer prognosis in a synergistic manner. Based on several
independent breast cancer datasets, we demonstrate that the proposed method can
identify better prognostic markers that have improved reproducibility and higher
discriminative power compared to the markers identified by previous methods. Pre-
liminary results of this work have been originally presented at [32].
3.2 Materials and Methods
3.2.1 Datasets
We obtained four independent breast cancer microarray gene expression datasets
from previous studies, which we refer to as the USA dataset (GSE2034) [6], Nether-
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lands dataset (NKI295) [18], Belgium dataset (GSE7390) [19], and Sweden dataset
(GSE1456) [20], respectively. The USA, Belgium, Sweden dataset were profiled on
the Affymetrix U133a platform and downloaded from the Gene Expression Omnibus
(GEO) website [24]. The Netherlands dataset was profiled on a custom Agilent
microarray platform and it was downloaded from the Stanford website [23]. The
USA dataset contains the gene expression profiles of 286 breast cancer patients,
the Netherlands dataset contains the profiles of 295 patients, the Belgium dataset
contains the profiles of 198 patients, and the Sweden dataset contains the profiles
obtained from 159 patients. In this study, gene expression profiles of the patients
for whom metastasis had been detected within 5 years of surgery were labeled as
“metastatic”, while the remaining profiles were labeled as “non-metastatic.” The
USA, Netherlands, Belgium, and Sweden datasets respectively contain 106, 78, 35,
and 35 metastatic profiles. The human protein-protein interaction network used in
this study was obtained from a previous study on subnetwork marker identification
by Chuang et al. [11], which consists of 11,203 proteins and 57,235 interactions. We
overlaid the gene expression data in the four breast cancer datasets with this PPI
network, by mapping each gene to the corresponding protein in the network. After
removing the proteins that do not have corresponding genes in all four datasets, we
obtained an induced network with 26,150 interactions among 4,936 proteins.
3.2.2 The Affinity Propagation Algorithm: A Brief Overview
In order to identify discriminative subnetwork markers, we apply affinity propa-
gation [33], an efficient clustering algorithm based on a message-passing approach.
In affinity propagation, real-valued messages are iteratively exchanged between data
points until a good set of exemplars (i.e., representative data points) are identified.
The data points are clustered around the exemplars that best represent them, which
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gives rise to clusters that consist of similar data points. During the message-passing
process, two different types of messages are exchanged between data points: respon-
sibility and availability. The responsibility r(i, k) measures the suitability of the data
point k to be an exemplar of the data point i, considering other potential exemplars.
The availability a(i, k) measures the appropriateness of choosing the data point k as
the exemplar for the data point i, based on the choice of other data points. At each
iteration, these messages are updated as follows:
r(i, k)← s(i, k)− max
k′ s.t. k′ 6=k
{
a(i, k
′
) + s(i, k
′
)
}
(3.1)
a(i, k)← min
0, r(k, k) + ∑
i′ s.t. i′ /∈{i,k}
max
{
0, r(i
′
, k)
} , (3.2)
where s(i, k) is the similarity between the data points i and k, used as the input of the
clustering algorithm. This similarity s(i, k) can be asymmetric. The self-availability
is updated in a slightly different way, as shown below:
a(k, k)←
∑
i′ s.t. i′ 6=k
max
{
0, r(i
′
, k)
}
. (3.3)
The data point k that maximizes the sum a(i, k) + r(i, k) is chosen as the exemplar
for the data point i, and the algorithm converges if the set of exemplars does not
change further.
So far, affinity propagation has been applied to various applications – such as
predicting genes from microarray data and clustering facial images – and it has been
shown to effectively identify meaningful clusters of data points at a much lower com-
putational cost than traditional clustering methods [33]. One important advantage
of affinity propagation is that the number of clusters need not be specified in ad-
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vance. This is especially useful in our current application, since we neither know how
many functional modules are embedded in the biological network at hand nor how
many of them are relevant to cancer prognosis, which makes it practically difficult
to determine how many subnetwork markers we should look for.
3.2.3 Computing the Similarity Between Genes
In our proposed method, we use affinity propagation to identify clusters – or
subnetworks – of discriminative and synergistic genes, whose protein products either
interact with each other or are closely located in the PPI network. In order to
use affinity propagation to identify the gene clusters, we first have to define the
similarity s(i, k) between gene gi and gk for all gene pairs. The characteristics of
the final clusters – especially, their usefulness as potential subnetwork markers –
will critically depend on how we define this similarity. For this reason, we take the
following points into consideration when defining s(i, k):
1. The proteins corresponding to the genes in the same cluster should have direct
interaction or should be closely located in the PPI network.
2. Every gene in a potential subnetwork marker should have sufficient discrimi-
native power to distinguish between the two class labels (metastatic vs. non-
metastatic).
3. The discriminative power to distinguish between the two class labels should be
increased by combining genes within the same cluster.
Based on these considerations, we define the similarity s(i, k) as follows:
s(i, k) = tk + min
{
tik − ti, tik − tk
}
− α
∣∣∣ti − tk∣∣∣ (3.4)
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if the shortest distance d(i, k) between the protein products of the genes gi and
gk in the PPI network satisfies d(i, k) ≤ 2. Otherwise, we set the similarity to
s(i, k) = −∞. The discriminative power of a given gene is measured in terms of
the t-test statistics score of the LLR between the two class labels, and ti and tk
are the t-test scores of gi and gk, respectively. Similarly, tik is the t-test score of
the combined LLRs of gi and gk which is computed by summing up the LLRs of
the two genes. This term, tik, reflects the discriminative power of the gene pair
(gi, gk) after combining them. The self-similarity was set to s(k, k) = c for all k,
where the constant c was chosen such that s(i, k) ≥ c for only 1% of all gene pairs
(gi, gk). Uniform initialization of the self-similarity s(k, k) = c guarantees that every
gene in the dataset gets equal chance to be an exemplar at the beginning of the
message-passing process.
As shown in (3.4), the similarity s(i, k) between gi and gk is defined in an asym-
metric way, where the the first term corresponds to the discriminative power of the
gene gk, the second term measures the improvement in discriminative power after
combining the two genes gi and gk, and the last term corresponds to a penalty term
for the difference between tk and ti. The parameter α ∈ [0, 1] is used to control the
penalty term. According to the above definition, gene gi regards gene gk as being
“similar” to itself:
1. if gk has high discriminative power (first term);
2. if combining the two genes increases the overall discriminative power;
3. if both genes have similar discriminative power.
The main reason underlying the asymmetric definition of the similarity s(i, k) is to
indicate the direction of similarity. Based on our asymmetric definition, the exem-
plars of the identified clusters tend to have higher discriminative power compared
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to other non-exemplars. Intuitively, the gene similarity defined in (3.4) will make
the affinity propagation algorithm identify gene clusters that consist of highly dis-
criminative genes that are synergistic to each other and whose protein products are
closely located in the PPI network.
3.2.4 Post-Processing the Identified Gene Subnetworks
Although the affinity propagation algorithm can effectively identify subnetworks
that consist of discriminative and synergistic genes, the clustering process does not
completely rule genes with relatively lower discriminative power out of those subnet-
works. As a result, the initial subnetworks that are predicted by affinity propagation
may still contain genes with relatively lower discriminative power compared to other
genes in the same subnetwork. In order to improve the overall discriminative power
of the potential subnetwork markers, we post-processed the initial subnetworks as
follows. First, we clustered the genes in a given subnetwork into k groups based
on their t-test statistics scores using the k-means clustering algorithm, where k was
chosen to be k = blog(# of gene in considered subnetwork) + 1c. After clustering,
the genes in the group with the lowest average t-test score were removed from the
subnetwork.
3.2.5 Probabilistic Inference of Subnetwork Activity
For estimating the activity level of a subnetwork based on the gene expres-
sion profile of a patient, we adopted the probabilistic pathway activity inference
method introduced in [13]. Given a subnetwork (or a pathway) with n member genes
G = {g1, g2, ..., gn} and the gene expression profile x = {x1, x2, ..., xn} of a patient,
where xi is the expression level of the gene gi, the activity level of the subnetwork is
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computed by:
A(x) =
n∑
i=1
λi
(
xi
)
, (3.5)
where λi(x
i) is the log-likelihood ratio between the two class labels (in this study,
metastatic vs. non-metastatic). This is given by
λi(x
i) = log
[
f 1i (x
i)/f 2i (x
i)
]
, (3.6)
where f ji (x
i) is the conditional probability density function (PDF) of xi under phe-
notype j. We assume that the gene expression level of gi under phenotype j follows
a Gaussian distribution.
3.3 Results
3.3.1 Statistics of the Identified Subnetwork Markers
For each of the four dataset, we identified potential subnetwork markers using
the proposed method and selected the top 50 markers based on their discriminative
power, measured in terms of the t-test statistics score of the subnetwork activity.
Three different values of α (= 0.2, 0.5, 0.8) were used in our experiments to investigate
the effect of the penalty term in (3.4) on the subnetwork marker identification result.
Table 3.1 shows the average size of the top 50 subnetworks markers for each dataset
and α. The last two columns in the table show the average size of the subnetwork
markers identified using the method proposed by Chuang et al. [11], which we refer
to as the “greedy” method, for simplicity. Two different values of r were used for
this greedy method. This parameter r specifies the minimum improvement rate of
the discriminative power of a subnetwork marker. The greedy method stops when
extending the subnetwork marker by adding a neighboring gene does not improve
the marker’s discriminative power by at least the specified rate r. We tested the
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greedy method with r = 0.05 (or 5% minimum required improvement) which is the
same as in [11]. We also tested the method with a lower rate r = 0.001 (or 0.1%
minimum required improvement) in order to allow the greedy search to continue even
if the improvement is not very significant and find out how a lower rate affects the
subnetwork size and its discriminative power. As we can see from Table 3.1, the
size of the network decreases as α gets larger. In fact, a large α tends to cluster
only genes with similar discriminative power (i.e., genes with similar t-test scores),
thereby yielding smaller subnetworks with fewer genes.
Table 3.1: Average size of the identified subnetwork markers [2].
Dataset Proposed Method greedy
α = 0.2 α = 0.5 α = 0.8 r = 0.05 r = 0.001
USA 52.58 35.58 16.96 3.94 5.22
Netherlands 52.62 31.2 15.9 5.18 7.20
Belgium 37.64 20.2 12.3 4.12 5.48
Sweden 33.18 21.38 14.16 3.66 4.82
Similar trends can be also observed in Table 3.2, which shows the total number
of unique genes in the top 50 subnetwork markers. As see can see in this table, a
larger α results in a smaller number of unique genes in the top subnetwork markers,
as each marker tends to get smaller.
Table 3.3 shows the total number of the common genes between the identified
subnetworks using different α. We can see that around 77% of genes included in
identified subnetworks using smaller α are also found in the subnetworks identified
with larger α.
We examined the overlap between the subnetworks identified on different datasets,
which is defined as the number of genes in the intersection divided by the number
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Table 3.2: Total number of unique genes in the identified subnetwork markers [2].
Dataset Proposed Method greedy
α = 0.2 α = 0.5 α = 0.8 r = 0.05 r = 0.001
USA 2,629 1,779 848 169 217
Netherlands 2,631 1,560 795 158 222
Belgium 1,916 1,010 615 113 149
Sweden 1,695 1,069 708 123 166
Table 3.3: Total number of common genes between the top subnetwork markers
identified using different α [2].
Dataset α = 0.2 ∩ α = 0.5 α = 0.2 ∩ α = 0.8 α = 0.5 ∩ α = 0.8
USA 1,612 660 561
Netherlands 1,382 646 488
Belgium 767 454 372
Sweden 802 466 387
of genes in the union. As shown in Table 3.4, we can see that the average overlap is
typically close to (or above) 20%, which is larger than the greedy method as well as
the overlap reported in [11] (12.7%).
Table 3.4: Overlap between the top subnetwork markers identified on different
datasets [2].
Dataset Proposed Method (α = 0.5) greedy
r = 0.05 r = 0.001
USA - Netherlands 25.10% 8.28% 7.60%
USA - Belgium 19.04% 5.22% 6.09%
USA - Sweden 19.71% 5.32% 5.51%
Netherlands - Belgium 18.11% 8.84% 10.09%
Netherlands - Sweden 18.85% 7.92% 7.78%
Belgium - Sweden 17.13% 11.57% 11.31%
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3.3.2 Computational Cost for Subnetwork Marker Identification
In order to evaluate the computational complexity of the proposed method, we
computed the total CPU time that is needed for identifying the top 50 subnetwork
markers on each dataset. We considered three different values of α (= 0.2, 0.5, 0.8)
that were used in our simulations. For comparison, we also estimated the total
CPU time for the greedy method that was previously proposed. It should be noted
that the two methods take completely different approaches for identifying multiple
markers. In our proposed method, all potential subnetwork markers (whose total
number exceeds 50) are simultaneously identified, hence we need to rank the potential
markers to select the top 50 markers with the highest discriminative power. As a
result, for our proposed method, the total CPU time includes the time for calculating
the similarity between genes, potential subnetwork marker identification through
affinity propagation, and post-processing and ranking the subnetwork markers. On
the other hand, for the greedy method, we measured the CPU time for calculating the
discriminative power of the genes and iteratively searching for the top 50 markers.
Since the greedy method finds one marker at a time, the search process needs to
be repeated to find multiple markers. Figure 3.1 shows the total CPU time of the
two methods for different parameters. All experiments were performed on a desktop
computer with a 3.06 GHz Intel Core i3 CPU and 4GB 1333 MHz DDR3 memory.
The results show that the proposed method is computationally more efficient for the
given task as it can simultaneously identify all potential markers without repeating
the search process multiple times. Unless one is interested in predicting only a few
top markers, the proposed method provides a clear advantage over the previous
greedy method. Figure 3.1 also shows that using different parameters do not affect
the overall CPU time significantly.
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Figure 3.1: Total CPU Time for identifying the top 50 subnetwork markers [2]. We
evaluated the computational complexity of the proposed method by estimating the
total CPU time needed for identifying the top 50 subnetwork markers in a given
dataset. We compared our method with the previously proposed greedy method for
a number of different parameters.
3.3.3 Discriminative Power of the Subnetwork Markers
We evaluated the discriminative power of the predicted subnetwork markers by
following a similar procedure as in previous studies [12, 13]. For each subnetwork
marker identified using the proposed method, we first inferred its activity level for
the gene expression profile of each patient, and then computed the t-test score of
the the inferred subnetwork activity level. Next, we sorted the subnetwork markers
according to their absolute t-test score in descending order. We then computed the
average absolute t-test score of the top K = 10, 20, 30, 40, 50 subnetwork markers, as
shown in Figure 3.2.
The horizontal axis in Figure 3.2 corresponds to K and the vertical axis cor-
responds to the mean absolute t-test score of the top K subnetwork markers. We
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Figure 3.2: Discriminative power of the identified subnetwork markers from various
methods [2]. We computed the mean absolute t-test statistics score of the top K=10,
20, 30, 40, and 50 subnetwork markers identified by different methods.
compared the discriminative power of the subnetwork markers predicted by the pro-
posed method with the discriminative power of the subnetworks predicted by the
greedy method proposed in [11]. The activity level of these subnetworks (identified
by the greedy method) was inferred based on the same scheme that was originally
used in [11]. As we can see from Figure 3.2, the proposed method typically finds
subnetwork markers with comparable or slightly higher discriminative power com-
pared to the previous greedy method, although both methods work very well. In this
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Figure 3.3: Comparison of discriminative power of subnetwork markers identified by 
the proposed method with and without post-processing step [2]. We computed the 
mean absolute t-score of the top K=10, 20, 30, 40, and 50 markers for all datasets 
identified by the proposed method with and without post-processing step.
experiment, the parameter α did not significantly affect the average discriminative
power of the subnetwork markers identified by the proposed method.
We also investigated the impact of the post-processing step by comparing the
discriminative power of the subnetwork markers before and after post-processing.
Figure 3.3 shows the results obtained using α = 0.5. We can see that the dis-
criminative power of the top 50 subnetwork markers improves as a result of the
post-processing step, during which we remove the genes that have relatively lower
discriminative power.
Next, to test the reproducibility of the subnetwork markers identified by the
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proposed method, we performed cross-dataset experiments as follows. First, we
identified subnetwork markers using the proposed method on one of the datasets
and ranked the markers based on their absolute t-test statistics score. After rank-
ing the subnetwork markers, we re-evaluated the discriminative power of the top 50
markers on a different dataset. This experiment allows us to find out how much
discriminative power is retained by the top predicted markers in a different, and
independent, dataset. The cross-dataset experiments are shown in Figure 3.4 and
Figure 3.5, where we can see that the markers identified by the proposed method
remain highly discriminative across datasets. This is in clear contrast to the sub-
network markers identified by the greedy method [11], for which we can typically
observe a sharp decrease in discriminative power when applied to an independent
dataset that was not used for predicting the markers. Interestingly, we can also
see that the proposed method finds effective markers that retain high discriminative
power even on an independent gene expression dataset profiled on a different mi-
croarray platform. For example, in Figure 3.4a, the subnetwork markers were first
identified using the USA dataset profiled on an Affymetrix chip, and then evaluated
on the Netherlands dataset profiled on a custom Agilent chip. Figure 3.4a shows
that the markers predicted by the proposed method using the first dataset can also
effectively discriminate between the two class labels based on the gene expression
profiles in the second dataset. Similar trends can also be observed in Figures 3.4d,
3.4e, 3.4f, 3.5b, and 3.5e.
One interesting observation we can make from these figures is that a smaller α
tends to yield subnetwork markers that retain their discriminative power relatively
better across independent datasets. This observation makes intuitively sense, since
a larger α tends to penalize genes with different discriminative power thereby giving
rise to relatively smaller subnetwork markers that mostly consist of a few highly
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Figure 3.4: Discriminative power of subnetwork markers identified on USA and
Netherlands datasets [2]. We computed the mean absolute t-score of the top K=10,
20, 30, 40, and 50 markers for all datasets. The markers were identified using the
first dataset and their discriminative power was evaluated on the second dataset.
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Figure 3.5: Discriminative power of subnetwork markers identified on Belgium and
Sweden datasets [2]. We computed the mean absolute t-score of the top K=10, 20,
30, 40, and 50 markers for all datasets. The markers were identified using the first
dataset and their discriminative power was evaluated on the second dataset.
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discriminative genes that may not be necessarily synergistic. This increases the risk
of overfitting the data, thereby degrading the effectiveness of the predicted markers
on other independent datasets.
3.3.4 Evaluating the Reproducibility of the Predicted Subnetwork Markers
In order to evaluate the efficacy of the predicted subnetwork markers in cancer
prognosis, we performed five-fold cross-validation experiments based on a similar
set-up that has been commonly used in previous studies [1, 11–14].
Considering that our ultimate goal is to identify effective subnetwork markers that
can be used for building robust classifiers that can accurately predict breast cancer
prognosis, it is important to verify whether the predicted markers can actually lead
to better classifiers whose performance can be reproduced on independent datasets.
For this purpose, we performed the following cross-dataset experiments.
First of all, we selected one of the four breast cancer datasets just for identifying
the potential subnetwork markers and selecting the optimal feature set (i.e., the set
of markers to be used for building the classifier). To select the optimal set of features,
we randomly divided the chosen dataset into three folds, where two folds (marker-
evaluation set) were used for evaluating the discriminative power of the subnetwork
markers and the remaining one fold (feature-selection set) was used for selecting the
features to be used in the classifier. We used the entire set for estimating the class
conditional probability density functions that are needed for the pathway activity
inference [13].
We evaluated the discriminative power of all potential subnetwork markers based
on the marker-evaluation set, selected the top 50 markers, and sorted them according
to their absolute t-test score in descending order. Initially, we built a classifier based
on LDA, where only the top subnetwork marker was included in the feature set. The
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classifier was trained on the marker-evaluation set and its classification performance
was assessed by measuring the AUC on the feature-selection set. Subsequently,
we added the next best subnetwork marker to the feature set, re-trained and re-
evaluated the classifier, and kept the subnetwork marker only if the AUC increased.
We repeated this process for the top 50 subnetwork markers.
Next, we chose a different dataset to train an LDA classifier (using the markers
selected from the first dataset) and evaluate its performance. For this, the second
dataset was randomly divided into five folds, where four folds were used for training
(without reselecting the features) and the rest was used for computing the AUC. The
entire process was repeated for 100 random partitions and we report the average AUC
as the performance measure. Similar experiments have been performed to evaluate
the classification performance of previous methods, including the greedy subnetwork
marker identification method [11] as well as a number of pathway-based classification
methods: Rank-LLR [1], LLR [13], Mean, and Median [9]. Each method uses a
different way to infer the pathway activity level based on the expression levels of its
gene members. For example, Mean (or Median) method uses the mean (or median)
expression value of the member genes that belong to the same pathway. LLR and
Rank-LLR both utilize the log-likelihood ratio between different phenotypes based
on the expression level of each member gene. For pathway markers, we selected the
top 50 pathways among the 880 pathways in the C2 curated gene sets in MsigDB [29].
Figure 3.6 summarizes the classification performance of different methods, where we
can clearly see that the proposed method leads to more reliable classifiers with much
more consistent performance across different breast cancer datasets.
Finally, we also performed within-dataset experiments to investigate the per-
formance of the proposed method, and compare it with previous subnetwork and
pathway-based methods. In these experiments, the classifiers were trained and eval-
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Figure 3.6: Reproducibility of various subnetwork and pathway markers [2]. In
order to evaluate the reproducibility of various modular markers, we used the first
dataset to identify potential markers and select the optimal set of features and the
second dataset to train the classifier (using the selected features) and evaluate its
performance.
uated on different folds of the same dataset, where a similar five-fold cross-validation
set-up was used as before. We first selected a dataset and then randomly divided
it into five folds. Four out of the five folds were used as a training set for build-
ing the classifier. The remaining one fold was used as a test set for evaluating the
classification performance. The subnetwork markers were identified using the entire
dataset, and not just the four fold training set, due to the high computational burden
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Figure 3.7: Classification performance [2]. We performed cross-validation experi-
ments to evaluate the classification performance of several subnetwork and pathway
marker identification methods. The marker were identified using the entire dataset.
The classifiers were trained and evaluated on different folds of the same dataset.
for re-identifying the subnetwork markers every time for a large number of random
partitions. The results are depicted in Figure 3.7. We can see that classifiers based
on subnetwork markers performed significantly better compared to those based on
pathway markers. The main reason for this significant performance improvement
is the substantially increased coverage of genes, which was the main motivation for
identifying subnetwork markers and using them for cancer classification. The pro-
posed subnetwork marker identification method and the greedy method performed
both well in the within-dataset experiments, although our proposed method outper-
formed the greedy method in terms of robustness and reproducibility across different
datasets as we have shown before.
3.4 Conclusions
In this chapter, we proposed a novel method for identifying robust and synergistic
subnetwork markers that can be used to accurately predict breast cancer prognosis.
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Our proposed method utilizes an efficient message-passing algorithm called affinity
propagation [33] to identify gene subnetworks that consist of discriminative and
synergistic genes whose protein products are known to interact with each other or to
be closely located in the protein-protein interaction network. The proposed method
allows us to simultaneously identify multiple mutually exclusive subnetwork markers
that have the potential to synergistically improve the prediction of breast cancer
prognosis. Extensive evaluation based on four large-scale breast cancer datasets
demonstrates that the proposed method can predict effective subnetwork markers
with high discriminative power and reproducible performance across independent
datasets. Furthermore, the predicted markers can be used to construct robust cancer
classifiers that can yield more consistent classification performance across datasets
compared to other existing methods.
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4. INCORPORATING TOPOLOGICAL INFORMATION FOR PREDICTING
ROBUST CANCER SUBNETWORK MARKERS IN HUMAN
PROTEIN-PROTEIN INTERACTION NETWORK∗
4.1 Introduction
In the previous chapter, we utilized a message-passing clustering algorithm to
identify subnetwork markers with high-accuracy disease prediction. The method
is capable to simultaneously predict multiple non-overlapping subnetwork markers
which may lead to cover more genes with lower computational cost compared to the
existing methods.
With these advantages, we adopt our previous message-passing based approach
while incorporating the topological information from the PPI network to identify
the potential functional modules–or subnetworks. Initially, we adopt widely made
assumptions that densely connected subnetworks may likely be potential functional
modules and that proteins that are not directly connected but interact with similar
sets of other proteins may share similar functionalities. We employ association indices
to estimate the topological information.
Association indices have been shown to be one of powerful tools for measuring
similarity between genes [34]. For example, Jaccard index has been successfully used
to measure neighborhood similarity for clustering and constructing Power Graph in
the work of Royer et al. [35].
In this chapter, we propose a novel method for incorporating PPI network topo-
logical information to enhance identification of subnetwork markers for predicting
∗Part of this chapter is reprinted from “Navadon Khunlertgit, and Byung-Jun Yoon. In-
corporating topological information for predicting robust cancer subnetwork markers in human
protein-protein interaction network. BMC Bioinformatics, vol. 17, no. 13, p. 351, 2016.
doi:10.1186/s12859-016-1224-1” [3] c© [2016] Navadon Khunlertgit and Byung-Jun Yoon.
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cancer prognosis. We utilize various association coefficients to estimate the topo-
logical similarity and also apply different approaches to integrate into our previous
message-passing based method. We assess the identified subnetwork markers and
evaluate their discriminative power and their classification performance through ex-
periments using publicly available independent breast cancer gene expression datasets
and PPI networks.
4.2 Materials and Methods
4.2.1 Datasets
In this study, we obtained two independent breast cancer microarray gene ex-
pression datasets from the public domain, which we refer to as GSE2034 [6] and
NKI295 [18]. GSE2034 was profiled on the Affymetrix U133a platform (GPL96) and
downloaded from the GEO database [36]. NKI295 was profiled on Agilent Hu25K
platform and downloaded from the supplement information from Chang et al. [23].
We used both datasets as published by their original studies. GSE2034 contains
expression profiles of 286 breast cancer patients, NKI295 contains expression profiles
of 295 patients. For 108 patients in GSE2034 and 78 patients in NKI295, metastasis
had been detected within 5 years of surgery. We labeled them as “metastatic”, while
the remainder was labeled as “non-metastatic”.
Four publicly available human PPI networks were used in this study which we
refer to as Chuang, HPRD, GASOLINE, and BioGRID. Chuang was obtained from
a previous study by Chuang et al. [11]. HPRD was downloaded from the Human
Protein Reference Database Release 9 [37]. GASOLINE was obtained from the work
of Micale et al. [38]. It was derived from STRING database [39] considering only
experimentally verified protein interactions. BioGRID was downloaded from the
Biological General Repository for Interaction Datasets version 3.4.134 (Homo Sapi-
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ens) [40]. We did not combine all the PPI networks because they were compiled
based on different criteria and domain of interest.
Table 4.1 shows the number of unique proteins and interactions for each PPI
network. BioGRID contains the largest number of interactions while HPRD contains
the largest number of proteins.
Table 4.1: The number of proteins and interactions for each PPI network [3].
PPI network Number of unique proteins Number of interactions
Chuang 11,203 57,235
HPRD 30,047 41,327
GASOLINE 9,556 53,859
BioGRID 20,364 315,507
We overlaid the gene microarray datasets with each PPI network by mapping
each gene to its corresponding protein in the network. After removing the proteins
that do not have corresponding genes in both gene expression datasets, we obtained
an induced networks with the statistics shown in Table 4.2. After data integration,
the numbers of proteins are quite similar to each other. BioGRID still contains the
largest number of interactions while the others contain approximately the same.
Table 4.2: The number of proteins and interactions for each induced PPI network [3].
PPI network Number of unique proteins Number of interactions
Chuang 5,293 26,773
HPRD 4,762 18,684
GASOLINE 4,277 22,253
BioGRID 5,697 99,426
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4.2.2 Affinity Propagation-Based Subnetwork Identification
We adopt the subnetwork identification procedure from our previous study [2],
where we utilized a message-passing clustering algorithm, called affinity propagation,
to cluster genes whose protein products interact with each other or are closely located
in PPI network. The input of this clustering algorithm is the measure of similarity
between genes. We originally defined the similarity of genes based entirely on the
discriminative power to distinguish between the two class labels as follows:
sDP (i, k) = tk + min {tik − ti, tik − tk} − α|ti − tk| (4.1)
where ti, and tk are t-test statistics score of the log-likelihood ratio (LLR) between
metastatic and non-metastatic samples of genes i, and k, respectively. tik is the t-test
score of the summation of the LLRs of genes i, and k.
The LLR, λ, of gene i, λ(xi), is based on probabilistic inference strategy proposed
in [13] and it is computed by
λ(xi) = log
[
f 1(xi)/f
2(xi)
]
, (4.2)
where xi is the expression level of the gene i and f
j(xi) is the conditional Gaussian
probability density function of xi under phenotype j.
The last term is the penalty term measured by the difference between discrim-
inative power of considering genes. The parameter, α, is defined between [0, 1] to
control this term. It is shown in our previous work [2] that the size of the network
decreases as α gets larger. It is because a larger α tends to cluster genes with similar
discriminative power. As a result of that, it yields small subnetworks with fewer
genes.
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The Equation 4.1 is based on original assumptions that when considering simi-
larity between two genes, the gene itself should have high discriminative power, com-
bining both genes as subnetwork should increase the overall discriminative power,
and both genes should have similar discriminative power.
4.2.3 Incorporating Topological Information for Computing the Similarity Between
Genes
With the assumption that the proteins corresponding to the genes in the same
subnetwork should have common topological attributes, we consider two following
points:
• Densely connected subnetworks may likely be potential functional modules.
• Proteins that are not directly connected but interact with similar sets of other
proteins may share similar functionalities.
Based on these considerations, we incorporate the topological information of pro-
teins in the PPI network by measuring their association coefficient–or topological
similarity.
We measure topological attribute using different types of association coefficients.
Let Ni and Nk be the neighborhood binary vectors of protein i and k. We define the
topological similarity between proteins i and k, sT (i, k), based on different similarity
indexes as follows:
1. Jaccard index: We define topological similarity, sTJ (i, k), as
sTJ (i, k) =
|Ni ∩Nk|
|Ni ∪Nk| (4.3)
Jaccard index is widely used to quantify the similarity
51
2. Kulczyn´ski index: This measure, sTK (i, k), represents the average proportion
of the number of common neighbors to the total number of neighbors of each
protein. It is given by
sTK (i, k) =
1
2
(
|Ni ∩Nk|
|Ni| +
|Ni ∩Nk|
|Nk| ) (4.4)
3. Tversky index: We define topological similarity based on Tversky index, sTT (i, k),
as
sTT (i, k) =
|Ni ∩Nk|
|Ni ∩Nk|+ aTT |Ni −Nk|+ bTT |Nk −Ni|
(4.5)
In order to indicate the direction of similarity (asymmetric similarity), we let
aTT = 1 and bTT = 0. This asymmetric definition lets the exemplars of the
identified clusters be more densely connected than other non-exemplars. We
can rewrite the equation as followings
sTT (i, k) =
|Ni ∩Nk|
|Ni| (4.6)
Tversky index can be viewed as a general form of Tanimoto coefficient (Jaccard
index) when aTT = 1 and bTT = 1, and Dice coefficient when aTT = 0.5 and
bTT = 0.5.
We do not include other similarity indices whose results are in the same order
(no alteration in the ranks) because they give the same output when applying affin-
ity propagation. For example, Dice coefficient, (2·|Ni∩Nk|)|Ni|+|Nk| , and Jaccard index share
similar results in terms of ranking. Ochiai index (or Cosine index), |Ni∩Nk|√|Ni|·|Nk| , and
Geometric index, |Ni∩Nk|
2
|Ni|·|Nk| provide the same ranks as of Kulczyn´ski index.
As we focus on retrieving topological information from the PPI network, we do
not make use of the number of common non-neighbor proteins |¬Ni ∩ ¬Nk| in this
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study.
Finally, we add the topological similarity, (4.3), (4.4), and (4.6), to the compu-
tation of similarity between genes i and k, s(i, k), in two different ways.
1. Similarity between genes i and k, s(i, k), as a product of the topological similar-
ity sT (i, k) and the discriminative power based similarity sDP (i, k). We define
as:
s(i, k) = sT (i, k) · sDP (i, k) (4.7)
2. Similarity between genes i and k, s(i, k), as a combination of the topological
similarity sT (i, k) and the discriminative power based similarity sDP (i, k). We
first scale the discriminative power based similarity sDP (i, k) into the range
[0, 1] as same as topological similarity’s by
sˆDP (i, k) =
sDP (i, k)−min(sDP )
max(sDP )−min(sDP ) (4.8)
where sDP is the set of all discriminative power based similarity of all gene
pairs. Then, we combine them as follows
s(i, k) = β(sT (i, k)) + (1− β)(sˆDP (i, k)) (4.9)
where β = [0, 1] is used to control the magnitude between each similarity.
Topological similarity, sT (i, k), has more effects as β increases. It should be
noted that s(i, k) can be viewed as the summation of topological similarity and
discriminative power based similarity when β = 0.5.
We use the same setting for preference as in [2]. The self-similarity is set to s(k, k) = c
for all k, where s(i, k) ≤ c for only 1% of all gene pairs (gi, gk) to guarantee that every
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gene gets equal chance to be an exemplar at the initial stage of clustering process.
4.2.4 Probabilistic Inference of Subnetwork Activity
To estimate the modular—or subnetwork—activity of identified subnetwork, we
employ the probabilistic inference method proposed in [13] which is the aggregation
of the LLRs of all member genes to represent the activity level of the subnetwork
markers, A(G). It is computed by
A(G) =
n∑
i=1
λ (xi) , (4.10)
where xi is the expression level of the gene gi in the subnetwork G = {g1, g2, ..., gn}.
This inference method can be viewed as the aggregation of the probabilistic evidence
of the expression level of genes in the subnetworks.
4.2.5 Experimental Setup
We identified subnetwork markers incorporating three different strategies to mea-
sure topological similarity which we referred to as Jaccard-based, Kulczyn´ski-based,
and Tversky-based. As mentioned previously, we used two different approaches to
integrate topological similarity to measure similarity between genes: 1) Product of
topological and discriminative power based similarity, namely, “product-based ap-
proach”, and 2) Linear combination of topological and discriminative power based
similarity, namely, “linear-combination-based approach”. In the latter approach, we
used three different values of β(= 0.25, 0.5, 0.75) to investigate the impact of topo-
logical similarity to the subnetwork identification. In fact, we can also setup the
experiments the other way around to find the optimal the value of β for each data.
After computing similarity between genes and applying affinity propagation-based
subnetwork identification, all output clusters were ranked based on the t-test statis-
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tics score of their activity level. Then we selected the top 50 clusters with high
discriminative power as the potential subnetwork markers for assessing their classi-
fication performance.
We repeated these processes to both gene expression datasets and all four PPI
networks.
4.3 Results
For comparison, we also evaluated the method proposed in [11], and [2] which
we refer to as the ‘greedy’ method, and the ‘AP-based’ method, respectively. We
applied the greedy method with 5% minimum required improvement which is the
same setting as originally published in [11]. In the AP-based method, we set the
magnitude of the penalty term, α, to 0.5 by reason shown in [2] that it yields high
and consistent classification performance as of smaller α with the smaller size of
identified subnetworks compared to larger α.
For simplicity in displaying Tables and Figures in this section, we abbreviate
Jaccard-based, Kulczyn´ski-based, and Tversky-based to jac, kul, and tve, respec-
tively. The suffixes, p, and lc are appended to indicate product-based approach,
and linear-combination-based approach, respectively.
4.3.1 Statistics of the Subnetwork Markers
Table 4.3 shows the average size of top 50 highly discriminative subnetwork mark-
ers identified by each method on GSE2034 and NKI295. Each column shows the re-
sults for each PPI network. The average size of markers identified by product-based
and linear-combination-based approach is similar to the original AP-based method.
We can clearly see that the average size of top markers identified by the proposed
method and AP-based is larger than the greedy-based.
As we can see from Table 4.3, the average size of top 50 highly discriminative
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Table 4.3: The average size of top 50 highly discriminative subnetwork markers from
GSE2034 and NKI295 [3].
Gene expression dataset = GSE2034
Methods Chuang HPRD GASOLINE BioGRID
Greedy 3.1 3.26 3.54 3.66
AP-based 36.28 35.78 34.18 38.78
jac p 18.06 19.94 19.58 29
kul p 21.16 25.32 22.48 36.28
tve p 34.48 45.26 45.98 61.8
β = 0.25 18.3 21.36 23.14 34
jac lc β = 0.5 15.08 15.38 16.44 24.24
β = 0.75 13.28 16.34 13.44 19.18
β = 0.25 24 30.14 28.68 39.02
kul lc β = 0.5 18.98 22.86 24.18 38.32
β = 0.75 16.06 19.12 20.84 30.98
β = 0.25 34.1 46.58 43.44 53.54
tve lc β = 0.5 28.98 43.8 45.5 71.24
β = 0.75 22.92 44.78 46.32 82.66
Gene expression dataset = NKI295
Methods Chuang HPRD GASOLINE Biogrid
Greedy 4.12 3.68 4.46 4.42
AP-based 31.34 30.32 28.78 34.66
jac p 14.62 16 18.94 27.72
kul p 12.3 22.5 26.9 33.34
tve p 28.22 42.24 49.9 57.1
β = 0.25 15.14 16.8 19.66 30.06
jac lc β = 0.5 13.38 12.44 13.68 22.66
β = 0.75 11.54 12.88 10.78 17.98
β = 0.25 14.8 24.6 27.06 39.26
kul lc β = 0.5 15.9 18.5 23.28 33.96
β = 0.75 13.7 17.12 17.22 27.14
β = 0.25 30.76 41.78 48.66 52.44
tve lc β = 0.5 27.26 41.62 50.7 72.88
β = 0.75 18.52 43.22 48.24 81.42
subnetwork markers increases as the PPI network with larger number of interac-
tions and unique proteins is used. This trend can be clearly seen when BioGRID is
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employed. Among product-based approach group, Tversky-based similarity, tve p,
yields larger subnetworks. In linear-combination-based approach, we can see that
the average size decreases as β increases in most cases. However, we cannot see this
trend distinctly in Tversky-based, tve lc. The main reason is that Tversky-based
similarity mostly provides higher similarity index compared with the others as it is
designed to indicate the direction of the similarity. For instance, when a gene shares
all of its neighbors with another gene (|Ni ∩ Nk| = |Ni|), it returns the maxi-
mum similarity (sTT (i, k) = 1), whereas the other topological similarities yield lower
because they depend on the number of neighbors the both genes.
As defined in Equation 4.9, the clustering process relies more on topological
information as β gets larger. Therefore, in this case, more genes tend to be clustered
into the same subnetwork.
We can see the similar trends for the number of unique genes in top 50 discrimi-
native subnetwork markers as shown in Table 4.4. We can also clearly see that the
top markers identified by the proposed method and AP-based cover more genes than
the greedy-based. The larger unique genes covered show that the proposed method
may increase the chance to discover genes that are not known to be related to the
disease. This also means the higher probability of identifying new subnetwork and
pathway.
Next, we studied the overlap between the top 50 highly discriminative subnet-
work markers identified on different gene expression datasets. The proposed method
yield larger overlap when comparing to all of the previous methods as shown in Ta-
ble 4.5. Again, similar trends as in Table 4.3 can also be observed here. The larger
overlaps show that more of common genes are covered and shared among identified
subnetworks from independent dataset from different platforms. This may lead us
to more robust classifiers, we demonstrate the robustness by providing classification
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Table 4.4: The number of unique genes in top 50 highly discriminative subnetwork
markers from GSE2034 and NKI295 [3].
Gene expression dataset = GSE2034
Methods Chuang HPRD GASOLINE Biogrid
Greedy 130 121 140 139
AP-based 1814 1789 1709 1939
jac p 903 997 979 1450
kul p 1058 1266 1124 1814
tve p 1724 2263 2299 3090
β = 0.25 915 1068 1157 1700
jac lc β = 0.5 754 769 822 1212
β = 0.75 664 817 672 959
β = 0.25 1200 1507 1434 1951
kul lc β = 0.5 949 1143 1209 1916
β = 0.75 803 956 1042 1549
β = 0.25 1705 2329 2172 2677
tve lc β = 0.5 1449 2190 2275 3562
β = 0.75 1146 2239 2316 4133
Gene expression dataset = NKI295
Methods Chuang HPRD GASOLINE Biogrid
Greedy 114 110 118 150
AP-based 1567 1516 1439 1733
jac p 731 800 947 1386
kul p 615 1125 1345 1667
tve p 1411 2112 2495 2855
β = 0.25 757 840 983 1503
jac lc β = 0.5 669 622 684 1133
β = 0.75 577 644 539 899
β = 0.25 740 1230 1353 1963
kul lc β = 0.5 795 925 1164 1698
β = 0.75 685 856 861 1357
β = 0.25 1538 2089 2433 2622
tve lc β = 0.5 1363 2081 2535 3644
β = 0.75 926 2161 2412 4071
performance charts showing that the experimental results from the proposed method
are consistent in the next section.
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Additionally, we analyzed enriched functions of the genes in the subnetwork mark-
ers using Panther [41], a web-based system designed to facilitate analysis of large
numbers of genes and provide comprehensive function information which includes
up-to-date comprehensive Gene Ontology (GO) annotations (GO database version
1.2, released 2016-05-20 with 44,588 total annotations). An example of the enrich-
ment analysis of the top 50 highly discriminative subnetworks identified using tve p
method on GASOLINE is shown in Table 4.6. We can see that the genes in identified
subnetworks from different gene expression datasets also share common GO terms.
4.3.2 Discriminative Power of the Subnetwork Markers
We evaluated the discriminative power of the subnetwork markers based on the
same procedure as previously used in these studies [1, 12–14]. We computed the
t-test score of the inferred subnetwork activity level. And then we sorted the
Table 4.5: Overlap between the top subnetwork markers identified on different gene
expression datasets [3].
Methods Chuang HPRD GASOLINE Biogrid
Greedy 5.63% 4.05% 4.88% 3.96%
AP-based 24.90% 28.70% 27.71% 23.89%
jac p 37.89% 29.28% 32.01% 31.97%
kul p 15.38% 27.52% 26.49% 28.26%
tve p 25.80% 44.15% 50.57% 42.33%
β = 0.25 39.10% 22.54% 26.55% 30.20%
jac lc β = 0.5 53.51% 26.68% 26.87% 37.94%
β = 0.75 54.55% 31.74% 26.67% 40.12%
β = 0.25 12.73% 24.47% 27.90% 28.50%
kul lc β = 0.5 39.86% 28.29% 31.18% 33.26%
β = 0.75 50.61% 35.53% 31.42% 40.73%
β = 0.25 27.53% 44.47% 46.75% 36.57%
tve lc β = 0.5 32.14% 43.47% 52.41% 54.90%
β = 0.75 32.99% 50.94% 57.71% 69.05%
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Figure 4.1: Discriminative power of subnetwork markers identified on GSE2034 by
different methods [3]. We computed the average absolute t-test score of the top
K=10, 20, 30, 40, and 50 subnetwork markers identified on GSE2034 by various
methods for the following PPI datasets: (a) Chuang, (b) HPRD, (c) GASOLINE,
and (d) BioGRID.
absolute value in descending order. The average absolute t-test score of the top
K = 10, 20, 30, 40, 50 subnetwork markers is shown in Figure 4.1. We can see that the
discriminative power of subnetwork markers identified by product-based approach,
and linear-combination-based approach are considerably higher than the result of
the greedy method. Among product-based approach group, Tversky-based yields
the highest in most of the results.
We also assessed how the subnetwork markers identified on specific gene expres-
sion dataset perform in another independent dataset. We sorted the subnetwork
markers based on their t-test score of the inferred subnetwork activity level on one
dataset and we reevaluated the discriminative power on the other dataset. As shown
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Figure 4.2: Discriminative power of subnetwork markers identified on GSE2034 and
evaluated on NKI295 [3]. The markers were identified and ranked on GSE2034
and their discriminative power was evaluated on NKI295. We computed the mean
absolute t-score of the top K=10, 20, 30, 40, and 50 markers by different methods
for the following PPI datasets: (a) Chuang, (b) HPRD, (c) GASOLINE, and (d)
BioGRID.
in Figure 4.2, we can see that the trends of discriminative power of subnetwork
markers across different gene expression datasets are similar to those observed in
Figure 4.1. The analysis of discriminative power of the subnetwork markers identi-
fied on NKI295 data also shows a similar trend (Figures 4.3 and 4.4).
About the impact of different PPI networks, the PPI network with larger number
of interactions tends to yield the higher discriminative power. One of the reasons
may be that it contains more topological information which may help to measure
the similarity between genes. As intuitively expected, we can see that BioGRID is
advantageous to the other PPI networks because it contains the largest number of
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Figure 4.3: Discriminative power of subnetwork markers identified on NKI295 by
different methods [3]. We evalutated the discriminative power of the top K=10, 20,
30, 40, and 50 subnetwork markers identified on NKI295 by varied methods for the
following PPI datasets: (a) Chuang, (b) HPRD, (c) GASOLINE, and (d) BioGRID.
interactions (as shown in Figures 4.1(d) and 4.3(d)).
4.3.3 Evaluating the Reproducibility of the Identified Subnetwork Markers
In order to evaluate the reproducibility of subnetwork markers, we performed five-
fold cross-validation experiments based on a similar set-up that has been commonly
used in previous studies [1, 2, 11–14], where the entire process was repeated for 100
random partitions.
We identified potential subnetwork markers and selected the top 50 subnetworks
as a feature set for the classifier on one gene expression dataset. After that, we built
the LDA classifiers based on the selected features and evaluated the accuracy on
the other dataset. The classification performance assessed by the AUC is shown in
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Figure 4.4: Discriminative power of subnetwork markers identified on NKI295 and
evaluated on GSE2034 [3]. The markers were identified and sorted on NKI295 and
their discriminative power was evaluated on GSE2034. We repeated the cross-dataset
discriminative power assessment for the following PPI datasets: (a) Chuang, (b)
HPRD, (c) GASOLINE, and (d) BioGRID.
Figure 4.5. We can see that both product-based approach and linear-combination
based approach yield consistently high performance across different gene expression
datasets and PPI networks.
In this study, we use the term, ‘reproducibility’ in the sense of the ability to
identify common discriminative genes or subnetworks across different independent
datasets. Therefore, using these subnetworks as biomarkers for disease classification
may lead to consistent performance. Furthermore, in terms of reproducibility in
practical usage, the AP-based methods, including our proposed methods, cost less
computation time compared to the greedy algorithm as shown in [2].
63
0.5
0.55
0.6
0.65
0.7
0.75
Av
er
ag
e	
AU
C
Chuang
HPRD
GASOLINE
Biogrid
(a)
0.5
0.55
0.6
0.65
0.7
Av
er
ag
e	
AU
C
Chuang
HPRD
GASOLINE
Biogrid
(b)
Figure 4.5: Reproducibility of subnetwork markers identified by various methods [3].
The bars show the cross-dataset classification performance (average AUC) of different
methods. (a) GSE2034 was used for identifying the potential markers and NKI295
was used for training and evaluating the classifier, (b) We repeated as NKI295 was
used for identifying the markers and GSE2034 was used for training and evaluation
of the classifier.
4.4 Conclusions
In this chapter, we propose a novel method that incorporates topological informa-
tion to identify subnetwork markers that can be used in cancer prognosis prediction.
We demonstrate how widely used association coefficients, such as Jaccard index,
Kulczyn´ski index, and Tversky index can be utilized to measure topological simi-
larity. Also, we show how to integrate these measures by two different approaches,
product-based, and linear-combination based.
Based on our experimental results, Tversky-based strategy is most suitable to
measure similarity between genes when the direction of interaction is involved. It
yields consistently high discriminative power across different datasets. Furthermore,
utilizing the larger PPI network with larger number of unique proteins and interac-
tions, such as BioGRID, may lead to the better subnetwork identification with higher
classification performance.
The proposed method considerably increases the coverage of genes and also the
64
overlap of genes when identified across different independent datasets. Through ex-
tensive evaluations using various independent breast cancer gene expression datasets
and PPI networks, the experimental results show that our method leads to the iden-
tification of robust and reproducible subnetwork markers that may lead to better
cancer classification.
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Table 4.6: The number of genes in top 50 highly discriminative subnetwork markers
from tve p method on GASOLINE categorized by their GO terms [3].
Ontology: Molecular function
GO term GO id GSE2034 NKI295
transporter activity GO:0005215 240 251
translation regulator activity GO:0045182 37 41
protein binding transcription factor activity GO:0000988 35 42
enzyme regulator activity GO:0030234 193 205
catalytic activity GO:0003824 1146 1221
channel regulator activity GO:0016247 5 6
receptor activity GO:0004872 346 370
nucleic acid binding transcription factor activity GO:0001071 307 316
antioxidant activity GO:0016209 8 6
structural molecule activity GO:0005198 226 260
binding GO:0005488 1237 1330
Ontology: Cellular component
GO term GO id GSE2034 NKI295
synapse GO:0045202 15 15
cell junction GO:0030054 13 11
membrane GO:0016020 288 290
macromolecular complex GO:0032991 213 214
extracellular matrix GO:0031012 50 58
cell part GO:0044464 765 794
organelle GO:0043226 411 441
extracellular region GO:0005576 151 153
Ontology: Biological process
GO term GO id GSE2034 NKI295
cellular component organization or biogenesis GO:0071840 278 309
cellular process GO:0009987 1559 1679
localization GO:0051179 536 577
apoptotic process GO:0006915 174 194
reproduction GO:0000003 104 118
biological regulation GO:0065007 886 933
response to stimulus GO:0050896 547 593
developmental process GO:0032502 634 692
rhythmic process GO:0048511 3 1
multicellular organismal process GO:0032501 393 413
locomotion GO:0040011 20 24
biological adhesion GO:0022610 127 147
metabolic process GO:0008152 1773 1876
growth GO:0040007 1 3
immune system process GO:0002376 314 342
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5. OVERALL CONCLUSIONS
In this dissertation, we proposed several methods for utilizing known biological
knowledge with gene expression data to identify disease-related modular markers for
predicting breast cancer metastasis. Our aim is to improve accuracy, robustness, and
reproducibility of the biomarkers.
In chapter 2, we proposed an improved pathway activity inference scheme – called
rank-based pathway activity inference – by integrating two effective strategies which
are the probabilistic pathway activity inference and the ranking-based relative gene
expression analysis approach. We showed that the proposed method can identify
more reproducible pathway markers with higher discriminative power. It can lead to
better classifiers that yield more consistent performance across datasets from different
platforms and normalization techniques.
In chapter 3, we proposed a new method for identifying subnetwork markers
by utilizing a message-passing clustering algorithm, called affinity propagation. We
also proposed a strategy to measure the similarity between genes based on gene ex-
pression data and its overlaid PPI networks in order to provide the input to the
clustering algorithm. We demonstrated that the proposed method can simultane-
ously predict non-overlapping subnetwork markers with high discriminative power
and reproducible performance across independent datasets.
In chapter 4, we enhanced the affinity propagation-based subnetwork identifica-
tion proposed in chapter 3 by incorporating topological information. We utilized vari-
ous association coefficients and suggested multiple approaches to integrating topolog-
ical information into the previously proposed method. We showed that the proposed
method increases the coverage of genes and identifies more common genes across
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different gene expression datasets and PPI networks. The proposed method leads to
the identification of robust and reproducible subnetwork markers.
All of the proposed methods in this dissertation are shown to improve the iden-
tification of potential modular biomarkers associated with breast cancer metastasis
based on biological knowledge, such as pathway information or PPI networks. This
improvement may lead to better cancer classification.
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